C.Q. Pharmaceutical Holding Co., Ltd. (SHE:000950)
China · Delayed Price · Currency is CNY 6.03
+0.03 (0.50%)
At close: Feb 6, 2026
SHE:000950 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 374.78 | 282.99 | 624.63 | 952.28 | 1,005 | 884.34 |
Depreciation & Amortization | 448.8 | 448.8 | 396.81 | 403.9 | 312.62 | 124.75 |
Other Amortization | 93.72 | 93.72 | 48.52 | 33.17 | 37.51 | 26.58 |
Loss (Gain) From Sale of Assets | -10.53 | -10.53 | -0.79 | -10.05 | -3.52 | -21.62 |
Asset Writedown & Restructuring Costs | 40.21 | 40.21 | 20.49 | 27.93 | 10.67 | 14.76 |
Loss (Gain) From Sale of Investments | -409.33 | -409.33 | -317.71 | -305.8 | -429.57 | -301.22 |
Provision & Write-off of Bad Debts | 531.72 | 531.72 | 388.33 | 124.48 | 282.22 | 101.09 |
Other Operating Activities | 2,027 | 1,299 | 1,505 | 1,336 | 1,053 | 788.23 |
Change in Accounts Receivable | -1,663 | -1,663 | -5,316 | -3,878 | -3,989 | -2,343 |
Change in Inventory | -1,432 | -1,432 | -752.22 | -1,824 | -185.46 | -51.37 |
Change in Accounts Payable | 728.6 | 728.6 | 4,007 | 3,401 | 2,183 | 1,439 |
Operating Cash Flow | 633.27 | -186.74 | 508.53 | 285.83 | 250.16 | 631.99 |
Operating Cash Flow Growth | 94.81% | - | 77.92% | 14.26% | -60.42% | 212.23% |
Capital Expenditures | -308.47 | -250.53 | -244.41 | -268.07 | -489.55 | -378.16 |
Sale of Property, Plant & Equipment | 0.72 | 1.4 | 0.83 | 6.59 | 11.65 | 27.56 |
Cash Acquisitions | 2.98 | -109.33 | -187.75 | -226.86 | -650.59 | -1,491 |
Divestitures | 0.4 | - | -28.9 | 81.85 | 33.3 | - |
Investment in Securities | 157.18 | 41.04 | 68.49 | 168.16 | -39.84 | -185.95 |
Other Investing Activities | 36.95 | 85.54 | 24.94 | 47.09 | 165.52 | 41.04 |
Investing Cash Flow | -60.83 | -182.46 | -358.38 | -191.24 | -969.51 | -1,957 |
Long-Term Debt Issued | - | 24,230 | 25,555 | 24,481 | 28,019 | 22,651 |
Long-Term Debt Repaid | - | -23,652 | -26,513 | -21,746 | -24,862 | -20,440 |
Net Debt Issued (Repaid) | -1,418 | 578.14 | -958.02 | 2,735 | 3,157 | 2,211 |
Issuance of Common Stock | - | - | - | - | 41.9 | - |
Common Dividends Paid | -997.06 | -1,120 | -1,299 | -928.81 | -1,227 | -664.92 |
Other Financing Activities | 736.33 | 590.28 | 2,510 | -626.11 | -429.17 | 81.35 |
Financing Cash Flow | -1,679 | 48.33 | 252.49 | 1,180 | 1,542 | 1,627 |
Foreign Exchange Rate Adjustments | - | - | - | - | -0.12 | -0.01 |
Net Cash Flow | -1,107 | -320.87 | 402.64 | 1,274 | 822.74 | 301.83 |
Free Cash Flow | 324.79 | -437.27 | 264.13 | 17.76 | -239.38 | 253.82 |
Free Cash Flow Growth | 466.11% | - | 1386.93% | - | - | - |
Free Cash Flow Margin | 0.39% | -0.54% | 0.34% | 0.03% | -0.38% | 0.56% |
Free Cash Flow Per Share | 0.18 | -0.25 | 0.15 | 0.01 | -0.14 | 0.15 |
Cash Income Tax Paid | 1,353 | 1,438 | 1,755 | 1,384 | 1,351 | 983.63 |
Levered Free Cash Flow | -101.19 | -1,389 | 1,225 | -2,481 | -3,830 | -5,510 |
Unlevered Free Cash Flow | 438.52 | -677.52 | 2,063 | -1,778 | -3,139 | -5,087 |
Change in Working Capital | -2,463 | -2,463 | -2,157 | -2,276 | -2,018 | -984.93 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.